(GTIV) Gentiva Health Services – Bear of the Day

We have downgraded our recommendation on Gentiva Health Services (GTIV) to Underperform, prompted by poor operating performance coupled with weakening financial position. The company’s second-quarter earnings lagged the Zacks Consensus Estimate, on the back of high interest payments as well as increased expenses, resulting in a deteriorated cash position.

However, the strong growth in Hospice segment, driven by the Odyssey acquisition, led to a huge surge in revenue, which was offset by the rising costs. The company needs to engage in effective cost control, while continuing its current acquisition strategy.

Overall, the future outlook for Gentiva does not look very promising. Our six-month target price of $6.25 equates to 3.0x our earnings estimate for 2011. This price target implies an expected total negative return of 8.4% over that period.

GENTIVA HEALTH (GTIV): Free Stock Analysis Report

Zacks Investment Research

About vitalstocks

This is a sample profile field. Vitalstocks is the operating company for Stockbloghub. This will place the picture of the author or company in the profile. Here is another extra line of information.


Powered by Facebook Comments

Similar Posts: | | Healthcare | Home Health Care

RSS feeds: Gentiva Health Services Inc. | GTIV | Healthcare | Home Health Care |

Other Posts by | RSS Feed for this author